Imaging specific cell surface protease activity in living cells using reengineered bacterial cytotoxins

Methods in Molecular Biology

Volumn 539, Issue , 2009, Pages 115-129

  Hobson, John P ^a   Liu, Shihui ^a   Leppla, Stephen H ^a   Bugge, Thomas H ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

lactamase; Anthrax toxin; CCF2 AM; Cell surface proteolysis; Flow cytometry; Fluorescence microscopy; Fluorescence plate reader; Furin; Metalloproteinases; Urokinase plasminogen activator.

Indexed keywords

BACTERIA (MICROORGANISMS);

ANTHRAX TOXIN; BACTERIAL ANTIGEN; BACTERIAL TOXIN; BETA LACTAMASE; FURIN; HYBRID PROTEIN; METALLOPROTEINASE; UROKINASE;

ANIMAL; ARTICLE; CELL CULTURE; CELL MEMBRANE; CHEMISTRY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENETICS; HUMAN; METABOLISM; METHODOLOGY; MOLECULAR BIOLOGY;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL TOXINS; BETA-LACTAMASES; CELL MEMBRANE; CELLS, CULTURED; FLOW CYTOMETRY; FURIN; HUMANS; METALLOPROTEASES; MICROSCOPY, FLUORESCENCE; MOLECULAR BIOLOGY; RECOMBINANT FUSION PROTEINS; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 77955140461     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-60327-003-8_7     Document Type: Article

References (27)

1. Werb Z. (1997) ECM and cell surface proteolysis: regulating cellular ecology. Cell 91 (4), 439-42. (Pubitemid 27508232)
2. Andreasen PA, Egelund R, Petersen HH. (2000) The plasminogen activation system in tumor growth, invasion, and metastasis. Cell Mol Life Sci 57 (1), 25-40. (Pubitemid 30105328)
3. McCawley LJ, Matrisian LM. (2000) Matrix metalloproteinases: multifunctional contributors to tumor progression. Mol Med Today 6 (4), 149-56. (Pubitemid 30171365)
4. Turk B, Turk D, Turk V. (2000) L ysosomal cysteine proteases: more than scavengers. Biochim Biophys Acta 1477 (1-2), 98-111. (Pubitemid 30119895)
5. Koblinski JE, Ahram M, Sloane BF. (2000) Unraveling the role of proteases in cancer. Clin Chim Acta 291 (2), 113-35. (Pubitemid 30089760)
6. Davie EW, Fujikawa K, Kisiel W. (1991) The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 30 (43), 10363-70.
7. Bugge TH. Proteolysis in carcinogenesis. (2003) In: Ensley JF, Gutkind JS, Jacob JR, Lippman SM Head and Neck Cancer. San Diego: Academic Press, 137-49.
8. Mohamed MM, Sloane BF. (2006) Cysteine cathepsins: multifunctional enzymes in cancer. Nat Rev Cancer 6 (10), 764-75. (Pubitemid 44450465)
9. Coussens LM, Fingleton B. (2002) Matrisian LM. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295 (5564), 2387-92. (Pubitemid 34270240)
10. McIntyre JO, Matrisian LM. (2003) Molecular imaging of proteolytic activity in cancer. J Cell Biochem 290 (6), 1087-97. (Pubitemid 37485047)
11. Sloane BF, Sameni M, Podgorski I, CavalloMedved D, Moin K. (2006) Functional imaging of tumor proteolysis. Annu Rev Pharmacol Toxicol 46, 301-15. (Pubitemid 43271192)
12. Hobson JP, Liu S, Rono B, Leppla SH, Bugge TH. (2006) Imaging specific cell-surface proteolytic activity in single living cells. Nat Meth 3 (4), 259-61.
13. Duesbery NS, Vande Woude GF. (1999) Anthrax toxins. Cell Mol Life Sci 55 (12), 1599-609. (Pubitemid 29445825)
14. Gordon VM, Klimpel KR, Arora N, Henderson MA, Leppla SH. (1995) Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases. Infect Immun 63 (1), 82-7.
15. Adachi M, Kitamura K, Miyoshi T, et al. (2001) Activation of epithelial sodium channels by prostasin in Xenopus oocytes. J Am Soc Nephrol 12 (6), 1114-21. (Pubitemid 32472624)
16. Liu S, Netzel-Arnett S, Birkedal-Hansen H, Leppla SH. (2000) Tumor cell-selective cytotoxicity of matrix metalloproteinase-activated anthrax toxin. Cancer Res 60 (21), 6061-7.
17. Liu S, Aaronson H, Mitola DJ, Leppla SH, Bugge TH. (2003) Potent antitumor activity of a urokinase-activated engineered anthrax toxin. Proc Natl Acad Sci USA 100 (2), 657-62. (Pubitemid 36126108)
18. Liu S, Schubert RL, Bugge TH, Leppla SH. (2003) Anthrax toxin: structures, functions and tumour targeting. Expert Opin Biol Ther 3 (5), 843-53. (Pubitemid 36934981)
19. Leppla SH, Arora N, Varughese M. (1999) Anthrax toxin fusion proteins for intracel-lular delivery of macromolecules. J Appl Microbiol 187 (2), 284.
20. Arora N, Leppla SH. (1993) Residues 1-254 of anthrax toxin lethal factor are sufficient to cause cellular uptake of fused polypeptides. J Biol Chem 268 (5), 3334-41. (Pubitemid 23070965)
21. Zlokarnik G, Negulescu PA, Knapp TE, et al. (1998) Quantitation of transcription and clonal selection of single living cells with beta-lactamase as reporter. Science 279 (5347), 84-8. (Pubitemid 28079160)
22. Liu S, Bugge TH, Leppla SH. (2001) Targeting of tumor cells by cell surface uroki-nase plasminogen activator-dependent anthrax toxin. J Biol Chem 276 (21), 17976-84.
23. Ke SH, Coombs GS, Tachias K, Navre M, Corey DR, Madison EL. (1997) Distinguishing the specificities of closely related proteases. Role of P3 in substrate and inhibitor discrimination between tissue-type plasminogen activator and urokinase. J Biol Chem 272 (26), 16603-9. (Pubitemid 27276491)
24. Ke SH, Madison EL. (1997) Rapid and efficient site-directed mutagenesis by singletube 'megaprimer' PCR method. Nucleic Acids Res 25 (16), 3371-2. (Pubitemid 27338700)
25. Coombs GS, Bergstrom RC, Pellequer JL, et al. (1998) Substrate specificity of prostate-specific antigen (PSA). Chem Biol 5 (9), 475-88. (Pubitemid 28436726)
26. Inglese J, Johnson RL, Simeonov A, et al. (2007) High-throughput screening assays for the identification of chemical probes. Nat Chem Biol 3 (8), 466-79. (Pubitemid 47080373)
27. Arora N, Leppla SH. (1994) Fusions of anthrax toxin lethal factor with shiga toxin and diphtheria toxin enzymatic domains are toxic to mammalian cells. Infect Immun 62 (11), 4955-61. (Pubitemid 24332801)